GENX — Genix Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- CA$1.53m
- CA$2.79m
- CA$0.00m
Annual balance sheet for Genix Pharmaceuticals, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.697 | 0.139 | 0.009 | 0.012 | 0.011 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.008 | 0.005 | 0.017 | 0.001 | 0.006 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.716 | 0.188 | 0.24 | 0.216 | 0.039 |
| Net Property, Plant And Equipment | — | 0.032 | 0.004 | 0 | — |
| Net Intangible Assets | |||||
| Total Assets | 5.35 | 4.77 | 4.25 | 0.223 | 0.046 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.35 | 0.744 | 1.05 | 1.36 | 1.23 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.49 | 0.755 | 1.05 | 1.36 | 1.23 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.86 | 4.01 | 3.2 | -1.14 | -1.18 |
| Total Liabilities & Shareholders' Equity | 5.35 | 4.77 | 4.25 | 0.223 | 0.046 |
| Total Common Shares Outstanding |